|Eales disease—an update|
J Biswas, T Sharma, L Gopal, HN Madhavan, KN Sulochana, ...
Survey of ophthalmology 47 (3), 197-214, 2002
|Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish|
M Farooq, KN Sulochana, X Pan, J To, D Sheng, Z Gong, R Ge
Developmental biology 317 (1), 336-353, 2008
|Biochemistry of homocysteine in health and diseases|
S Ramakrishnan, KN Sulochana, S Lakshmi, R Selvi, N Angayarkanni
|Smoking of beedies and cataract: cadmium and vitamin C in the lens and blood.|
S Ramakrishnan, KN Sulochana, T Selvaraj, AA Rahim, M Lakshmi, ...
British journal of ophthalmology 79 (3), 202-206, 1995
|Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration|
K Coral, R Raman, S Rathi, M Rajesh, KN Sulochana, N Angayarkanni, ...
Eye 20 (2), 203-207, 2006
|Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis|
KN Sulochana, H Fan, S Jois, V Subramanian, F Sun, RM Kini, R Ge
Journal of Biological Chemistry 280 (30), 27935-27948, 2005
|Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice|
W Xiang, Z Ke, Y Zhang, G Ho‐Yuet Cheng, ID Irwan, KN Sulochana, ...
Journal of cellular and molecular medicine 15 (2), 359-374, 2011
|Ornithine and its role in metabolic diseases: An appraisal|
M Sivashanmugam, J Jaidev, V Umashankar, KN Sulochana
Biomedicine & Pharmacotherapy 86, 185-194, 2017
|Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study|
T Sharma, L Gopal, RK Reddy, N Kasinathan, NA Shah, ...
Retina 25 (2), 152-157, 2005
|Developing antiangiogenic peptide drugs for angiogenesis-related diseases|
KN Sulochana, R Ge
Current pharmaceutical design 13 (20), 2074-2086, 2007
|CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells|
G Narayanan, H Vuyyuru, B Muthuvel, S Konerirajapuram Natrajan
PloS one 8 (9), e71982, 2013
|Effect of oral supplementation of free amino acids in type 2 diabetic patients--a pilot clinical trial.|
S Lakshmi, R Punitham, T Arokiasamy, B Sukumar, S Ramakrishnan
Medical science monitor: international medical journal of experimental and …, 2002
|Beneficial effect of lysine and amino acids on cataractogenesis in experimental diabetes through possible antiglycation of lens proteins|
KN Sulochana, R Punitham, S Ramakrishnan
Experimental eye research 67 (5), 597-601, 1998
|Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage|
V Bhooma, KN Sulochana, J Biswas, S Ramakrishnan
Current eye research 16 (2), 91-95, 1997
|Decrease in glycation of lens proteins by lysine and glycine by scavenging of glucose and possible mitigation of cataractogenesis|
S Ramakrishnan, KN Sulochana
Experimental eye research 57 (5), 623-628, 1993
|Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous|
KN Sulochana, J Biswas, S Ramakrishnan
Current eye research 19 (3), 254-259, 1999
|Trace elements iron, copper and zinc in vitreous of patients with various vitreoretinal diseases|
NS Konerirajapuram, K Coral, R Punitham, T Sharma, N Kasinathan, ...
Indian journal of ophthalmology 52 (2), 145-8, 2004
|Involvement of oxidative and nitrosative stress in promoting retinal vasculitis in patients with Eales’ disease|
M Rajesh, KN Sulochana, R Punitham, J Biswas, S Lakshmi, ...
Clinical biochemistry 36 (5), 377-385, 2003
|Copper transporters and chaperones: Their function on angiogenesis and cellular signalling|
SRB Devi, A Dhivya M, KN Sulochana
Journal of biosciences 41, 487-496, 2016
|The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor|
S Sharghi-Namini, H Fan, KN Sulochana, P Potturi, W Xiang, YS Chong, ...
Biochemical and Biophysical Research Communications 371 (2), 215-219, 2008